Form NPORT-P Investment Managers Seri For: Jun 30
Tweet
Share
E-mailSerious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Genentech Announces Positive Phase II Results for Dual GLP-1/GIP Receptor Agonist Enicepatide in People Living With Type 2 Diabetes and Overweight or Obesity
- Weekly progress on share repurchase program to cover share plans and reduce capital
- Invest $1K Now, Secure $20K at Launch! Is This New Presale Crushing 7 Top 100x Meme Coins?
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
